EUVIMEDEUVIMED entdecken
Open Access

Bayesian two-sample survival probability curves with comparative summary measures and sensitivity analyses

Michelle Leeberg, Thomas A Murray, Xianghua Luo

Contemporary Clinical Trials · 2026-11 · 170 · 108478

DOI: 10.1016/j.cct.2026.108478 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Contemporary Clinical Trials, 2026-11. Verfasst von Michelle Leeberg und 2 weiteren Autor:innen. Beteiligte Einrichtung: Abbott Cardiovascular, 5050 Nathan Lane North, Plymouth, MN 55442, USA. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Two-sample survival probability curves (TSSPCs) provide a concise way to visualize treatment differences in randomized controlled trials (RCTs). In this paper, we propose various area under the curve (AUC) metrics for TSSPCs as numerical measures for treatment effects. First, in the same spirit as the restricted mean survival time, we propose the restricted AUC (R-AUC) for the TSSPC. This metric can be estimated regardless of incomplete curve estimates caused by censoring and has a clear probabilistic interpretation. Additionally, we introduce sensitivity analysis measures, the worst- and best-case AUC (W-AUC and B-AUC), to represent extreme scenarios of the treatment effect beyond a specified restriction time point. We further propose to estimate the TSSPC and AUC measures using Bayesian models, and compare them against their counterparts derived from the Kaplan-Meier (KM) and Cox proportional hazards (PH) model frameworks. Using simulations and real oncology RCT data, we demonstrate that all methods perform well when the PH assumption holds. However, when the PH assumption is violated, the proposed Bayesian estimators outperform the Cox model in our simulations and data examples. Across all studied scenarios, the proposed person-period Bayesian approach offers flexibility comparable to the KM approach, while producing smoother curve estimates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicHumansBayes TheoremProportional Hazards ModelsSurvival AnalysisArea Under CurveComputer SimulationKaplan-Meier Estimate

Stichwörter der Autor:innen

Area under the curveClinical trialsGraphical methodSurvival analysisTime-to-eventTreatment effect

Autor:innen und Institutionen

  • Abbott Cardiovascular, 5050 Nathan Lane North, Plymouth, MN 55442, USA.
  • Division of Biostatistics and Health Data Science, University of Minnesota, 2221 University Avenue SE, Minneapolis, MN 55414, USA.
  • Division of Biostatistics and Health Data Science, University of Minnesota, 2221 University Avenue SE, Minneapolis, MN 55414, USA; Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA. Electronic a…

Förderung

  • NCI NIH HHS
  • National Institutes of Health National Cancer Institute

Zitieren

APA

Leeberg, M., Murray, T. A., & Luo, X. (2026). Bayesian two-sample survival probability curves with comparative summary measures and sensitivity analyses. Contemporary Clinical Trials, 170, 108478. https://doi.org/10.1016/j.cct.2026.108478

Vancouver

Leeberg M, Murray TA, Luo X. Bayesian two-sample survival probability curves with comparative summary measures and sensitivity analyses. Contemporary Clinical Trials. 2026;170:108478. doi:10.1016/j.cct.2026.108478

BibTeX
@article{Leeberg2026,
  author = {Leeberg, Michelle and Murray, Thomas A and Luo, Xianghua},
  title = {Bayesian two-sample survival probability curves with comparative summary measures and sensitivity analyses},
  journal = {Contemporary Clinical Trials},
  year = {2026},
  volume = {170},
  pages = {108478},
  doi = {10.1016/j.cct.2026.108478}
}
Kostenlos starten →